MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 62 filers reported holding MARRONE BIO INNOVATIONS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $18,000 | -30.8% | 16,485 | -53.7% | 0.00% | – |
| Q4 2021 | $26,000 | +62.5% | 35,638 | +94.6% | 0.00% | – |
| Q3 2021 | $16,000 | -48.4% | 18,309 | -3.2% | 0.00% | – |
| Q2 2021 | $31,000 | +47.6% | 18,920 | +85.2% | 0.00% | -100.0% |
| Q1 2021 | $21,000 | +61.5% | 10,217 | 0.0% | 0.00% | – |
| Q4 2020 | $13,000 | +8.3% | 10,217 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $12,000 | 0.0% | 10,217 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | – | 10,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
| ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
| Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
| WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
| Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
| Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
| AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |